LONDON, May 16 (Reuters) - Hikma Pharmaceuticals PLC HIK.L :

* Hikma pharmaceutical - interim management statement

* Branded and injectables businesses are on track to meet our current FY

guidance for 2013

* Now expect group revenue to grow by around 13% in 2013, up from our previous

guidance of around 10%

* On a constant currency basis, we continue to expect branded revenue growth to

be around 11% in 2013

Source Text for Eikon ID:nRS9MBWNd ((London Equities Newsroom; +44 20 7542 7717)) ((For more news, please click here HIK.L ))